• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2007-2017 年挪威报告的产志贺毒素大肠杆菌病例增加与胃肠道病原体多重 PCR 诊断方法的应用有关。

Implementation of multiplex PCR diagnostics for gastrointestinal pathogens linked to increase of notified Shiga toxin-producing Escherichia coli cases in Norway, 2007-2017.

机构信息

Department of Zoonotic, Food- and Waterborne Infections, Division for Infection Control and Environmental Health, Norwegian Institute of Public Health (NIPH), Postboks 4404, Nydalen, NO-0403, Oslo, Norway.

Faculty of Medicine, University of Oslo, Oslo, Norway.

出版信息

Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):801-809. doi: 10.1007/s10096-019-03475-5. Epub 2019 Jan 24.

DOI:10.1007/s10096-019-03475-5
PMID:30680573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6424946/
Abstract

The aim of this study was to investigate implementation of multiplex PCR assays (broad screening PCR) on the distribution and characteristics of notified Shiga toxin-producing Escherichia coli (STEC) cases in Norway, 2007-2017. We described STEC cases notified to the Norwegian Surveillance System for Communicable Diseases (MSIS), 2007-2017 and categorised cases as high-virulent, low-virulent or unclassifiable STEC infections based on guidelines for follow-up of STEC cases. We conducted descriptive analysis and time series analysis allowing for trends and seasonality, and calculated adjusted incidence rate ratios (aIRR) using negative binomial regression for laboratories with and without broad screening PCR. A total of 1458 STEC cases were notified to MSIS (2007-2017), median age 21 years, 51% female. Cases were categorised as having 475 (33%) high-virulent, 652 (45%) low-virulent, and 331 (23%) unclassifiable STEC infections. We observed a higher increasing monthly trend in cases (aIRR = 1.020; 95% CI 1.016-1.024) notified from laboratories with broad screening PCR (n = 4) compared to laboratories (n = 17) without (aIRR = 1.011; 95% CI 1.007-1.014). Notification of low-virulent STEC infections increased from laboratories with broad screening PCR. The increase in notified STEC cases was prominent in cases categorised with a low-virulent STEC infection and largely attributable to unselective screening methods. We recommend NIPH to maintain differentiated control measures for STEC cases to avoid follow-up of low-virulent STEC infections. We recommend microbiological laboratories in Norway to consider a more cost-effective broad screening PCR strategy that enables differentiation of high-virulent STEC infections.

摘要

本研究旨在调查挪威 2007-2017 年间多重 PCR 检测(广泛筛查 PCR)在 notified Shiga 毒素产生大肠杆菌(STEC)病例分布和特征中的应用。我们描述了 2007-2017 年向挪威传染病监测系统(MSIS)报告的 STEC 病例,并根据 STEC 病例随访指南将病例分为高毒力、低毒力或无法分类的 STEC 感染。我们进行了描述性分析和时间序列分析,以考虑趋势和季节性,并使用负二项回归计算了具有和不具有广泛筛查 PCR 的实验室的调整发病率比(aIRR)。共有 1458 例 STEC 病例向 MSIS 报告(2007-2017 年),中位年龄 21 岁,女性占 51%。病例被分为具有 475 例(33%)高毒力、652 例(45%)低毒力和 331 例(23%)无法分类的 STEC 感染。我们观察到,在具有广泛筛查 PCR 的实验室(n=4)报告的病例中,每月病例呈更高的上升趋势(aIRR=1.020;95%CI 1.016-1.024),而在没有广泛筛查 PCR 的实验室(n=17)中,每月病例呈上升趋势(aIRR=1.011;95%CI 1.007-1.014)。低毒力 STEC 感染的病例从具有广泛筛查 PCR 的实验室中报告的病例数量有所增加。在低毒力 STEC 感染分类的病例中,报告的 STEC 病例增加显著,这主要归因于无选择性筛查方法。我们建议 NIPH 维持针对 STEC 病例的差异化控制措施,以避免对低毒力 STEC 感染的随访。我们建议挪威的微生物学实验室考虑采用更具成本效益的广泛筛查 PCR 策略,以区分高毒力 STEC 感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/6424946/9e8722e3d8cc/10096_2019_3475_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/6424946/4ef26ab5946c/10096_2019_3475_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/6424946/243fa312d318/10096_2019_3475_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/6424946/9e8722e3d8cc/10096_2019_3475_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/6424946/4ef26ab5946c/10096_2019_3475_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/6424946/243fa312d318/10096_2019_3475_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/6424946/9e8722e3d8cc/10096_2019_3475_Fig3_HTML.jpg

相似文献

1
Implementation of multiplex PCR diagnostics for gastrointestinal pathogens linked to increase of notified Shiga toxin-producing Escherichia coli cases in Norway, 2007-2017.2007-2017 年挪威报告的产志贺毒素大肠杆菌病例增加与胃肠道病原体多重 PCR 诊断方法的应用有关。
Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):801-809. doi: 10.1007/s10096-019-03475-5. Epub 2019 Jan 24.
2
Do changes in STEC diagnostics mislead interpretation of disease surveillance data in Switzerland? Time trends in positivity, 2007 to 2016.STEC 诊断方法的变化是否会误导瑞士疾病监测数据的解释?2007 年至 2016 年的阳性率趋势。
Euro Surveill. 2020 Aug;25(33). doi: 10.2807/1560-7917.ES.2020.25.33.1900584.
3
Shiga toxin-producing escherichia coli infections in Norway, 1992-2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome.1992年至2012年挪威产志贺毒素大肠杆菌感染情况:分离株特征及溶血尿毒综合征风险因素的鉴定
BMC Infect Dis. 2015 Aug 11;15:324. doi: 10.1186/s12879-015-1017-6.
4
Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999-2008--a retrospective study of hospital records to assess the sensitivity of surveillance.1999-2008 年挪威儿童溶血尿毒综合征的发病和病因——一项评估监测敏感性的回顾性医院记录研究。
BMC Infect Dis. 2014 May 16;14:265. doi: 10.1186/1471-2334-14-265.
5
The emerging importance of Shiga toxin-producing other than serogroup O157 in England.在英国,除 O157 血清群以外的产志贺毒素大肠埃希菌的重要性日益凸显。
J Med Microbiol. 2021 Jul;70(7). doi: 10.1099/jmm.0.001375.
6
Implications of screening and childcare exclusion policies for children with Shiga-toxin producing Escherichia coli infections: lessons learned from an outbreak in a daycare centre, Norway, 2012.产志贺毒素大肠杆菌感染患儿的筛查及儿童保育排除政策的影响:从2012年挪威一家日托中心的疫情中吸取的教训
BMC Infect Dis. 2014 Dec 18;14:673. doi: 10.1186/s12879-014-0673-2.
7
Epidemiology and microbiology of Shiga toxin-producing Escherichia coli other than serogroup O157 in England, 2009-2013.2009-2013 年英格兰产志贺毒素大肠杆菌非 O157 血清群的流行病学和微生物学。
J Med Microbiol. 2014 Sep;63(Pt 9):1181-1188. doi: 10.1099/jmm.0.075895-0. Epub 2014 Jun 13.
8
Epidemiology of Shiga toxin producing Escherichia coli in Australia, 2000-2010.澳大利亚 2000-2010 年产志贺毒素大肠杆菌的流行病学研究。
BMC Public Health. 2012 Jan 21;12:63. doi: 10.1186/1471-2458-12-63.
9
Shiga toxin-producing Escherichia coli: incidence and clinical features in a setting with complete screening of patients with suspected infective diarrhoea.产志贺毒素大肠埃希菌:在对疑似感染性腹泻患者进行全面筛查的环境中的发生率和临床特征。
Clin Microbiol Infect. 2018 Jun;24(6):635-639. doi: 10.1016/j.cmi.2017.10.002. Epub 2017 Oct 10.
10
Molecular detection of Shiga toxin-producing Escherichia coli (STEC) O157 in sheep, goats, cows and buffaloes.检测绵羊、山羊、奶牛和水牛中的产志贺毒素大肠杆菌(STEC)O157。
Mol Biol Rep. 2021 Aug;48(8):6113-6121. doi: 10.1007/s11033-021-06631-3. Epub 2021 Aug 10.

引用本文的文献

1
The epidemiology of notifiable diseases in Australia and the impact of the COVID-19 pandemic, 2012-2022.2012 - 2022年澳大利亚法定传染病流行病学及2019冠状病毒病大流行的影响
BMC Glob Public Health. 2024 Jan 2;2(1):1. doi: 10.1186/s44263-023-00029-y.
2
A preliminary study of the use of MinION sequencing to specifically detect Shiga toxin-producing Escherichia coli in culture swipes containing multiple serovars of this species.使用 MinION 测序技术特异性检测培养拭子中多种血清型产志贺毒素大肠埃希菌的初步研究。
Sci Rep. 2023 May 22;13(1):8239. doi: 10.1038/s41598-023-35279-1.
3
Antimicrobial Resistance, Pathogenic, and Molecular Characterization of from Diarrheal Patients in South Korea.

本文引用的文献

1
The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2016.欧盟2016年人畜共患病、人畜共患病原体及食源性疾病暴发的趋势与来源总结报告
EFSA J. 2017 Dec 12;15(12):e05077. doi: 10.2903/j.efsa.2017.5077. eCollection 2017 Dec.
2
Shiga toxin-producing Escherichia coli: incidence and clinical features in a setting with complete screening of patients with suspected infective diarrhoea.产志贺毒素大肠埃希菌:在对疑似感染性腹泻患者进行全面筛查的环境中的发生率和临床特征。
Clin Microbiol Infect. 2018 Jun;24(6):635-639. doi: 10.1016/j.cmi.2017.10.002. Epub 2017 Oct 10.
3
韩国腹泻患者中[具体内容缺失]的抗菌药物耐药性、致病性及分子特征
Pathogens. 2022 Mar 23;11(4):385. doi: 10.3390/pathogens11040385.
4
Prevalence of genotypic antimicrobial resistance in clinical Shiga toxin-producing in Norway, 2018 to 2020.2018 年至 2020 年挪威产志贺毒素临床分离株的基因型抗菌药物耐药性流行情况。
J Med Microbiol. 2021 Dec;70(12). doi: 10.1099/jmm.0.001454.
5
Characterization of Shiga Toxin 2a Encoding Bacteriophages Isolated From High-Virulent O145:H25 Shiga Toxin-Producing .从高毒力产志贺毒素的O145:H25分离出的编码志贺毒素2a噬菌体的特性分析
Front Microbiol. 2021 Sep 8;12:728116. doi: 10.3389/fmicb.2021.728116. eCollection 2021.
6
Optimization of Notification Criteria for Shiga Toxin-Producing Escherichia coli Surveillance, the Netherlands.荷兰针对产志贺毒素大肠杆菌监测的通知标准优化。
Emerg Infect Dis. 2021 Jan;27(1):258-261. doi: 10.3201/eid2701.200339.
7
Do changes in STEC diagnostics mislead interpretation of disease surveillance data in Switzerland? Time trends in positivity, 2007 to 2016.STEC 诊断方法的变化是否会误导瑞士疾病监测数据的解释?2007 年至 2016 年的阳性率趋势。
Euro Surveill. 2020 Aug;25(33). doi: 10.2807/1560-7917.ES.2020.25.33.1900584.
8
Investigation of the Causes of Shigatoxigenic PCR Positive and Culture Negative Samples.产志贺毒素性PCR阳性且培养阴性样本的原因调查
Microorganisms. 2020 Apr 18;8(4):587. doi: 10.3390/microorganisms8040587.
9
Rapid culture-based identification of Shiga toxin-producing Escherichia coli and Shigella spp./Enteroinvasive E. coli using the eazyplex® EHEC complete assay.采用 eazyplex® EHEC complete 检测试剂盒进行基于快速培养的产志贺毒素大肠杆菌和志贺菌属/侵袭性大肠杆菌的鉴定。
Eur J Clin Microbiol Infect Dis. 2020 Jan;39(1):151-158. doi: 10.1007/s10096-019-03704-x. Epub 2019 Sep 16.
10
The importance of integrating genetic strain information for managing cases of Shiga toxin-producing infection.整合基因菌株信息对产志贺毒素感染病例管理的重要性。
Epidemiol Infect. 2019 Sep 9;147:e264. doi: 10.1017/S0950268819001602.
Incidence and Trends of Infections with Pathogens Transmitted Commonly Through Food and the Effect of Increasing Use of Culture-Independent Diagnostic Tests on Surveillance - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2013-2016.
通过食物常见传播的病原体感染的发病率及趋势以及增加使用非培养诊断检测对监测的影响——美国10个地点食源性疾病主动监测网络,2013 - 2016年
MMWR Morb Mortal Wkly Rep. 2017 Apr 21;66(15):397-403. doi: 10.15585/mmwr.mm6615a1.
4
Virulence factors of Shiga toxin-producing Escherichia coli and the risk of developing haemolytic uraemic syndrome in Norway, 1992-2013.产志贺毒素大肠杆菌的毒力因子与 1992-2013 年挪威溶血性尿毒综合征的发病风险。
Eur J Clin Microbiol Infect Dis. 2017 Sep;36(9):1613-1620. doi: 10.1007/s10096-017-2974-z. Epub 2017 Apr 8.
5
Haemolytic uraemic syndrome.溶血尿毒综合征。
Lancet. 2017 Aug 12;390(10095):681-696. doi: 10.1016/S0140-6736(17)30062-4. Epub 2017 Feb 25.
6
Secondary Shiga Toxin-Producing Escherichia coli Infection, Japan, 2010-2012.2010 - 2012年日本继发性产志贺毒素大肠杆菌感染
Emerg Infect Dis. 2016 Dec;22(12):2181-2184. doi: 10.3201/eid2212.160783.
7
Estimating true incidence of O157 and non-O157 Shiga toxin-producing Escherichia coli illness in Germany based on notification data of haemolytic uraemic syndrome.基于溶血性尿毒综合征的报告数据估算德国O157和非O157产志贺毒素大肠杆菌疾病的真实发病率。
Epidemiol Infect. 2016 Nov;144(15):3305-3315. doi: 10.1017/S0950268816001436. Epub 2016 Jul 29.
8
Multiplex Molecular Panels for Diagnosis of Gastrointestinal Infection: Performance, Result Interpretation, and Cost-Effectiveness.用于诊断胃肠道感染的多重分子检测板:性能、结果解读及成本效益
J Clin Microbiol. 2015 Dec;53(12):3723-8. doi: 10.1128/JCM.02103-15.
9
Shiga toxin-producing escherichia coli infections in Norway, 1992-2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome.1992年至2012年挪威产志贺毒素大肠杆菌感染情况:分离株特征及溶血尿毒综合征风险因素的鉴定
BMC Infect Dis. 2015 Aug 11;15:324. doi: 10.1186/s12879-015-1017-6.
10
Taxonomy Meets Public Health: The Case of Shiga Toxin-Producing Escherichia coli.分类学与公共卫生:以产志贺毒素大肠埃希菌为例。
Microbiol Spectr. 2014 Jun;2(3). doi: 10.1128/microbiolspec.EHEC-0019-2013.